MAPT and Alzheimer disease: Therefore, besides regulating synaptic-related proteins and transcription factors implicated in synaptic plasticity, miRNAs targeting genes related to Aβ and tau metabolism and activity can also contribute to synaptic dysfunction during AD, which may be further modulated by glial cells during neuroinflammation.